Medicare Enrolled

Dr. Jason Luke, M.D.

Hematology & Oncology · Pittsburgh, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
5150 CENTRE AVE, Pittsburgh, PA 15232
4126472811
In practice since 2008 (18 years)
NPI: 1093989196 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Luke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Luke? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Luke

Dr. Jason Luke is a hematology & oncology specialist in Pittsburgh, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Luke performed 211 Medicare services across 119 unique beneficiaries.

Between the years covered by Open Payments, Dr. Luke received a total of $369,936 from 37 pharmaceutical and/or device companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Luke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 211 Medicare services $369,936 industry payments

Medicare Practice Summary

Medicare Utilization ↗
211
Medicare services
Bottom 17% in PA for hematology & oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
119
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~12 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
79 $107 $256
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
78 $61 $180
New patient office visit, complex (60-74 min) 30 $139 $362
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $75 $188
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$369,936
Total received (2018-2024)
Avg $52,848/year across 7 years
Top 2% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$292,827 (79.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$49,166 (13.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,943 (7.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$57,512
2023
$53,761
2022
$49,757
2021
$41,773
2020
$20,021
2019
$62,051
2018
$85,061

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$24,158
Teva Pharmaceuticals USA, Inc.
$11,400
Regeneron Pharmaceuticals, Inc.
$8,094
E.R. Squibb & Sons, L.L.C.
$3,855
Genmab U.S., Inc.
$3,360
AstraZeneca UK Limited
$3,325
Regeneron Healthcare Solutions, Inc.
$2,288
PFIZER INC.
$938
AstraZeneca Pharmaceuticals LP
$95
Top 3 companies account for 75.9% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$54,328
Merck Sharp & Dohme LLC
$48,060
E.R. Squibb & Sons, L.L.C.
$42,143
EMD Serono, Inc.
$29,289
Bayer HealthCare Pharmaceuticals Inc.
$28,616
SERVIER PHARMACEUTICALS LLC
$21,852
Regeneron Pharmaceuticals, Inc.
$20,234
Novartis Pharmaceuticals Corporation
$15,699
Janssen Global Services, LLC
$14,992
Teva Pharmaceuticals USA, Inc.
$11,400
Regeneron Healthcare Solutions, Inc.
$8,862
Incyte Corporation
$8,649
ARRAY BIOPHARMA INC
$7,425
NOVARTIS PHARMACEUTICALS CORPORATION
$6,718
Bayer Healthcare Pharmaceuticals Inc.
$5,760
AstraZeneca UK Limited
$5,544
AstraZeneca Pharmaceuticals LP
$5,306
Krystal Biotech Inc
$4,030
Eisai Inc.
$3,745
ABBVIE INC.
$3,544
Genmab U.S., Inc.
$3,360
Janssen Research & Development, LLC
$2,701
G1 Therapeutics, Inc.
$2,480
Genentech, Inc.
$2,310
Servier BioInnovation
$2,170
EISAI INC.
$1,860
Alnylam Pharmaceuticals Inc.
$1,755
Novartis Pharma AG
$1,550
TESARO, Inc.
$1,382
Kadmon Corporation LLC
$1,200
PFIZER INC.
$938
Partner Therapeutics, Inc.
$620
Boehringer Ingelheim Pharmaceuticals, Inc.
$491
ModernaTX, Inc.
$468
F. Hoffmann-La Roche AG
$319
RefleXion Medical, Inc.
$93
Genentech USA, Inc.
$43
Top 3 companies account for 39.1% of all-time payments
Associated products mentioned in payments ›
AFINITOR · BRAFTOVI · Bavencio · CALQUENCE · COSELA · Epkinly · IMFINZI · JAKAFI · KEYTRUDA · LEUKINE · LIBTAYO · Lenvima · MEKINIST · Non-Covered Product · OPDIVO · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · TAFINLAR · TAFINLAR_ONCOLOGY · TAFMAK_MEKINIST · TECENTRIQ · Tepotinib · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 2% for hematology & oncology in PA.

Looking for a hematology & oncology specialist in Pittsburgh?
Compare hematology & oncology specialists in the Pittsburgh area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
114
Per 100K population
9.2
County median income
$76,393
Nearest hospital
WEST PENN HOSPITAL
1.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Luke is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 2% of PA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Luke experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Luke performed 79 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Luke receive payments from pharmaceutical companies?
Yes. Dr. Luke received a total of $369,936 from 37 companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Luke's costs compare to other hematology & oncology specialists in Pittsburgh?
Dr. Luke's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Luke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →